Big Move For Cue Biopharma, Inc.
Fri, Apr 10, 2026 at 07:22 PM
Cue Biopharma, Inc. (CUE:NASDAQ) rocketted at $0.5, representing a gain of 71.4%. On Fri, Apr 10, 2026, CUE:NASDAQ hit a New 2-Week High of $0.5. The stock appeared on our News Catalysts scanner on Thu, Apr 09, 2026 at 02:48 AM in the 'EARNINGS' category. From Fri, Mar 27, 2026, the stock recorded 55.56% Up Days and 40.00% Green Days
The stock spiked on Fri, Apr 10, 2026 at $0.67 with a volume of 230M+.
About Cue Biopharma, Inc. (CUE:NASDAQ)
Cue Biopharma Inc is a biopharmaceutical company developing a novel and proprietary class of biologic drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders.
Top 10 Gainers:
- Fusemachines Inc. (FUSE:NASDAQ), 115.29%
- Erayak Power Solution Group Inc. (RAYA:NASDAQ), 107.99%
- Smart Powerr Corp. (CREG:NASDAQ), 85.41%
- F45 Training Holdings Inc. (FXLV:NYSE), 76.47%
- Sky Quarry Inc. (SKYQ:NASDAQ), 72.7%
- Cue Biopharma, Inc. (CUE:NASDAQ), 71.36%
- XCF Global Inc. (SAFX:NASDAQ), 49.54%
- Rackspace Technology, Inc. (RXT:NASDAQ), 49.39%
- Zentalis Pharmaceuticals, Inc. (ZNTL:NASDAQ), 48.77%
- Solo Brands Inc. Class A (SBDS:NYSE), 43.78%